Geneos Wealth Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-116
| Closed | -$2.4K | – | 2101 |
|
|
2024
Q1 | $2.4K | Buy |
116
+16
| +16% | +$331 | ﹤0.01% | 1870 |
|
|
2023
Q4 | $2.31K | Hold |
100
| – | – | ﹤0.01% | 1896 |
|
|
2023
Q3 | $799 | Hold |
100
| – | – | ﹤0.01% | 2054 |
|
|
2023
Q2 | $870 | Buy |
+100
| New | +$870 | ﹤0.01% | 2033 |
|
|
2022
Q4 | – | Sell |
-100
| Closed | – | – | 2042 |
|
|
2022
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 2195 |
|
|
2022
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 2650 |
|
|
2022
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 2636 |
|
|
2021
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 2662 |
|
|
2021
Q3 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 2734 |
|
|
2021
Q2 | – | Sell |
-100
| Closed | -$1K | – | 2933 |
|
|
2021
Q1 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 3007 |
|